NIMH Chemical Synthesis and Drug Supply Program

Compounds Catalog

Click the NIMH number to see more information about the compound.
Click the order button to order that compound.
Type within the boxes at the top of any column to search for items in the catalog.

Download Catalog

Compounds Catalog, PDF, 3MB


MH No. Compound Name Indication Order
M-904 Mirapex (Pramipexole) A dopamine agonist used to treat Parkinson's disease.
E-902 Escitalopram Oxalate A selective serotonin reuptake inhibitor used to treat depression and anxiety.
O-902 Oxcarbazepine An anticonvulsant used to treat seizures in patients with epilepsy.
M-905 Mirtazapine A tetracyclic antidepressant used to treat severe depression.
L-902 Lamotrigine An anticonvulsant used to treat seizures and bipolar disorder.
V-901 Venlafaxine A serotonin and norepinephrine reuptake inhibitor used to treat depression.
A-907 Aripiprazole An antipsychotic used to treat schizophrenia and bipolar mania.
D-908 Duloxetine hydrochloride A selective serotonin and norepinephrine reuptake inhibitor used to treat depression.
B-903 Bupropion hydrochloride antidepressive agent; dopamine uptake inhibitor; smoking cessation treatment
R-903 Ropinirole hydrochloride A non-ergoline dopamine agonist used to treat Parkinson's disease.
S-909 Sertraline hydrochloride A selective serotonin reuptake inhibitor used to treat depression and OCD.
P-902 Paroxetine hydrochloride A serotonin reuptake inhibitor used to treat depression and panic disorders.
Z-903 Ziprasidone hydrochloride An atypical antipsychotic drug used to treat schizophrenia.
G-901 Gabapentin An anticonvulsant medication used to treat epilepsy and neuropathic pain.
D-909 Donepezil A reversible acetyl cholinesterase inhibitor used to treat Alzheimer's disease.
C-916 Coenzyme A-S-acetyl-7-hydroxynaphthylethylamine Ligand for melatonin rhythm enzyme arylalkylamine-N-acetyltransferase (AANAT).
C-915 Carnosine-d7 Use as internal standard in conjunction with LC/MS techniques to quantify carnosine.
A-908 Anserine-d4 Use as internal standard in conjunction with LC/MS techniques to quantify anserine.
F-905 3-Fluoro-5-{2-[2-(fluoromethyl)thiazol-4-yl]ethynyl}benzonitrile mGlur5 PET imaging ligand reference standard
I-904 2-[C3H3]I-NBMeO N-[2-C3H3O]benzyl-2’,5’-dimethoxy-4’-iodophenethylamine Selective 5HT2A/2C Agonist
B-904 3-{2-[2-(Bromomethyl)thiazol-4-yl]ethynyl}-5-fluorobenzonitrile mGlur5 PET imaging ligand precursor
D-910 2-Methyl-4-(1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine (N-Desmethylolanzapine) Metabolite of Olanzapine
P-903 3-{2-[4-(6-Fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl}-7-hydoxy-4-methyl-1,5-diazabicyclo[4.4.0]deca-3,5-dien-2-one (Paliperidone) Antischizophrenic; metabolite of resperidone
N-902 (+)-8-Chloro-5-(7-benzofuranyl)-7-hydroxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, [3H]NNC-01-0112 Tritium-labeled dopamine D1 receptor ligand
T-910 Tianeptine, sodium salt selective serotonin reuptake enhancer (SSRE)
B-905 N-Bromoacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline Peripheral benzodiazepine receptor PET ligand labeling precursor
F-906 N-Fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline Peripheral benzodiazepine receptor PET ligand reference standard
R-905 Ro 41-1049 hydrochloride [N-(2-Aminoethyl)-5-(3-fluorophenyl)-4-thiazole carboxamide hydrochloride] Selective, reversible, orally active MAO-A inhibitor
R-904 [3H]Ro 41-1049 {N-(2-Aminoethyl)-5-[2-3H](3-fluorophenyl)-4-thiazole carboxamide} Tritium-labeled, selective, reversible, orally active MAO-A inhibitor
H-909 N-(2-Hydroxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide Peripheral benzodiazepine receptors PET imaging ligand precursor.
M-907 N-(2-Methoxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide Peripheral benzodiazepine receptors PET imaging ligand reference standard
M-911 3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone O-Methyl-oxime (ABP688) Selective and high-affinity ligand for mGlu5 receptors
M-912 3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone oxime mGlu5 receptors PET imaging ligand precursor
M-908 (±)-Modafinil {(±)-2-[Di(phenyl)methanesulfinyl]acetamide} A psychostimulant drug for the treatment of narcolepsy.
M-909 R-(–)-Modafinil {R-(–)-[2-(Diphenyl)methanesulfinyl]acetamide} A CNS stimulant
M-910 S-(+)-Modafinil {S-(+)-[2-(Diphenyl)methanesulfinyl]acetamide} A CNS stimulant
M-913 2-[4’-(Methylamino)phenyl]-6-hydroxybenzothiazole (6-OH-BTA-1) Amyloid-b PET imaging agent Pittsburgh Compound-B (PIB) reference standard.
A-909 2-(4’-Aminophenyl)-6-methoxymethoxybenzothiazole (6-MOMO-BTA-0) Amyloid-b PET imaging agent Pittsburgh Compound-B (PIB) precursor.
A-911 6-Aminomethyl-3-methyl-4H-1,2,4-benzothiadazine-1,1-dioxide Hydrochloride Taurine antagonist
D-913 (E)-2,2-Diphenyl-5-{4-[(pyridin-3-yl-methylene)amino]piperazin-1-yl}pentanenitrile (SC-26196) Selective delta-6 desaturase inhibitor
A-910 (2S,3S,4R,5R,E)-N-Ethyl-3,4-dihydroxy-5-(6-(4-(6-(2-(4-(2-(4,4-difluoro-4,4a-dihydro-5-(thiophen-2-yl)4-bora-3a,4a-diaza-s-indacene-3-yl)vinyl)phenoxy)acetamido)hexanamido)butylamino)-9H-purin-9-yl)-tetrahydrofuran-2-carboxamide (ABEA-X-BY630) Red-emitting fluorescent adenosine receptor agonist
D-912 2-{4-[4-(2-Hydroxyphenyl)piperazin-1-yl]butyl}-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione (Desmethyl CUMI-101) 5-HT1A receptor PET imaging ligand precursor
C-917 2-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl}-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione (CUMI-101) 5-HT1A receptor PET imaging ligand reference standard
B-906 8-Bromo-6-phenyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylic acid ethyl ester Benzodiazepine intermediate for preparation of novel anxiolytic agent
M-914 1-(2-Methylbenzoxazol-6-yl)-3-[1,5]-naphthyridin-4-yl-urea (SB-334867) Selective non-peptide orexin-1 receptor antagonist.
I-905 2-Isopropylpentanoic acid Non-teratogenic constitutional isomer of the anticonvulsant drug valproic acid.
S-910 (R)-5,6-Dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one Maleate (Sumanirole Maleate) Selective and high-affinity dopamine D2 receptor agonist
D-914 (+)-(2R,3R,11bR)-10-Methoxy-3-(2-methylpropyl)-9-[11-(2,4,6-triethynylphenoxy)undecyloxy]- 1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol (DTBZ Derivative) Dihydrotetrabenazine derivative for preparation of magnetic resonance imaging (MRI) agent.
C-918 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) mGluR5 positive allosteric modulator
B-907 N-benzo[1,3]dioxol-5-yl-2-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H purin-8-yl)-1-methyl- 1H-pyrazol-3-yloxy]acetamide (MRE 2029-F20) A2B adenosine receptor antagonist.
B-908 N-benzo[1,3]dioxol-5-yl-2-[5-(2,6-dioxo-1,3-[2,3-3H]dipropyl-2,3,6,7-tetrahydro-1H purin-8-yl)-1-methyl- 1H-pyrazol-3-yloxy]acetamide ([3H]MRE 2029-F20) [3H]-labeled A2B adenosine receptor antagonist.
M-915 5-[(6-{[(5a,6a)-7,8-Didehydro-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-yl]oxy}hexyl)- disulfanyl]-2-nitrobenzoic acid (Morphine-SH-DTNB Derivative) Morphine derivative for preparation of protein disulfide conjugate.
N-903 2-Amino-1-(3,4-ditrimethylacetoxyphenyl)ethanol Hydrochloride (Norepinephrine Dipivalate Hydrochloride) Dipivalyl derivative and prodrug of norepinephrine
F-907 2-Amino-1-(3,4-ditrimethylacetoxy-6-fluorophenyl)ethanol Hydrochloride (6-Fluoronorepinephrine Dipivalate Hydrochloride) Dipivalyl derivative and prodrug of 6-fluoronorepinephrine
S-911 SKF-83566 Hydrobromide Dopamine D1 receptor antagonist.
B-912 {(R,S)-[(S)-1-(4-Bromophenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl}phosphonic Acid Hydrochloride (PEAQX Hydrochloride) NMDA receptor antagonist.
D-917 (R)-(+)-a-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol (Volinanserin) 5-HT2A receptor antagonist.
W-902 WIN 55212-2 Mesylate Cannabinoid receptor agonist.
A-917 (3-Aminopropyl)(diethoxymethyl)phosphinic Acid GABAB receptor antagonist.
P-904 Phenazepam A benzodiazepine derivative drug for the treatment of epilepsy, alcohol withdrawal syndrome or insomnia.
B-913 Bromazepam A benzodiazepine derivative drug for the treatment of anxiety or panic attacks.
E-903 Estazolam A benzodiazepine derivative drug for the treatment of insomnia.
A-918 4-Amino-1-tert-butyl-3-(1’-naphthylmethyl)pyrazolo[3,4-d]pyrimidine (1-NM-PP1) Tyrosine kinase inhibitor
G-902 [3H]D-Galactonic Acid
S-912 N-(1-Methyl-1H-indol-5-yl)-N'-(3-methylisothiazol-5-yl)urea (SB 204741) 5-HT2B receptor antagonist
P-905 Methyl (8-Chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol[1,5-a][1,4]benzodiazepin-3-yl)methyl Ether (PWZ-029) a5 GABAA receptor inverse agonist
C-921 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (Celecoxib) Selective cyclooxygenase-2 (COX-2) inhibitor.
C-922 4-Chloro-2-(4,5-dihydro-1H-imidazol-2-yl)-2,3-dihydro-1H-isoindole Hydroiodide (RS 45041-190 Hydroiodide) I2 imidazoline receptor ligand.
C-923 Chlordiazepoxide A benzodiazepine derivative drug with anxiolytic, skeletal muscle relaxant, hypnotic and amnestic properties.
D-920 Delorazepam A benzodiazepine derivative drug with anxiolytic, skeletal muscle relaxant, hypnotic and anticonvulsant properties.
P-906 (+)-(4aR,10bR)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol Hydrochloride [(+)-PHNO Hydrochloride] Dopamine D2/3 receptors agonist; PET ligand reference standard.
D-919 (+)-(4aR,10bR)-3,4,4a,5,6,10b-Hexahydro-2H-naphtho[1,2-b]-1,4-oxazine-9-ol Hydrochloride [(+)-N-Despropyl-PHNO Hydrochloride] Dopamine D2/3 receptors PET ligand labeling precursor.
N-905 (-)-(2S,4R)-1-{(3R)-5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl}-4-hydroxy-N,N-dimethyl- 2-pyrrolidine-carboxamide (Nelivaptan) Vasopressin receptor V1b antagonist
C-924 N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide (TA-2) Dopamine D4 receptor ligand
C-925 N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-hydroxybenzamide Dopamine D4 receptor PET ligand labeling precursor
C-926 N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-[3H]methoxybenzamide ([3H]TA-2) Tritium-labeled dopamine D4 receptor ligand
B-914 Benperidol Dopamine D2 receptors PET ligand labeling precursor
M-917 N-Methylbenperidol Antipsychotic; dopamine D2 receptors PET ligand reference standard
M-918 (RS)-1-[3-(Trimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenofuran-5-carbonitrile Iodide (N-Methyl-citalopram) Selective serotonin reuptake inhibitor (SSRI) that does not penetrate the mouse brain.
D-921 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine Dihydrochloride (SA-4503 Dihydrochloride) Sigma-1 receptor agonist.
D-922 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-N-methyl-2,2-diphenylbutanamide Hydrochloride (N-Desmethyl-loperamide Hydrochloride) P-glycoprotein PET reagent reference standard.
B-915 (1-Butylpiperidin-4-yl)methyl 4-Amino-3-methoxybenzoate 5-HT4 receptor PET ligand reference standard.
B-916 (1-Butylpiperidin-4-yl)methyl 4-Amino-3-hydroxybenzoate 5-HT4 receptor PET ligand labeling precursor.
V-903 2-Ethyl-3-methylvaleramide (Valnoctamide) An anticonvulsant that is about three times more potent than valproic acid and is not teratogenic.
M-919 4-[2-(Methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide Hydrochloride (LP-44) 5-HT7 receptor agonist
N-906 4-Nitrophenyl-4-[bis(1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate (JZL 184) Monoacylglycerol lipase (MAGL) inhibitor.
H-910 N-[2-(5-Hydroxy-6-fluoro-1H-indol-3-yl)ethyl]-2-oxopiperidine-3-carboxamide (6-Fluoro-HIOC) Fluorinated HIOC derivative
T-911 N-[2-(2-Trifluoromethyl-5-hydroxy-1H-indol-3-yl)ethyl]-2-oxopiperidine-3-carboxamide (2-Trifluoromethyl-HIOC) Fluorinated HIOC derivative
V-904 5-{4-[4-(5-Cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide Hydrochloride (Vilazodone Dihydrochloride) Antidepressant with a dual mechanism of 5-HT reuptake inhibition and 5-HT1A partial agonism.
B-917 Buprenorphine Hydrochloride High affinity partial mu-opioid receptor agonist.
C-927 (+)-6-((R)-2-{2-[4-(4-Chlorophenoxy)piperidin-1-yl]ethyl}pyrrolidine-1-sulphonyl)-1H-indole Hydrochloride (SB-656104-A) High-affinity, selective 5-HT7 antagonist.
C-928 (-)-6-((S)-2-{2-[4-(4-Chlorophenoxy)piperidin-1-yl]ethyl}pyrrolidine-1-sulphonyl)-1H-indole Hydrochloride Isomer of 5-HT7 antagonist SB-656104-A.
C-929 Clozapine-N-oxide Clozapine metabolite.
L-904 2-(6-Fluoro-1H-indol-3-yl)-N-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)ethanamine Hydrochloride (Lu AE58054) Selective 5­HT6 receptor antagonist.
L-905 9-Isopropyl-N-[3-(trifluoromethyl)benzyl]-9H-purin-6-amine (Longdaysin) CK1, ERK2 and CDK7 kinases inhibitor that results in a lengthening of circadian periods.
L-906 N-(1-(4-Iodobenzyl)piperidin-4-yl)-3-chlorophenylacetamide (LS-1-137) Selective sigma-1 receptor ligand.
S-913 2-Bromo-N-[4-chloro-3-[[(3R)-1-methyl-3-pyrrolidinyl]oxy]phenyl]-4,5-dimethoxybenzenesulfonamide (SB 657510) Selective urotensin-II (UT) receptor antagonist.
A-919 (±)-3-(4-Chlorophenyl)-3-[2-(dimethylamino)ethyl]-3,4-dihydro-1H-2-benzopyran-1-one Hydrochloride ((±)-AC 7954 Hydrochloride) Selective urotensin-II (UT) receptor agonist.
D-923 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-2,2-diphenylbutanamide (N-Didesmethyl-loperamide) P-glycoprotein PET ligand labeling precursor
P-907 N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide (PF 3845) Selective fatty acid amide hydrolase (FAAH) inhibitor.
M-920 (+)-4-(2-methoxyphenyl)-3,7,7-trimethyl-2H,4H,5H,6H,7H,8H,9H-pyrazolo[3,4-b]quinolin-5-one Serine/threonine kinase glycogen synthase kinase-3 (GSK3) inhibitor.
M-921 (-)-4-(2-methoxyphenyl)-3,7,7-trimethyl-2H,4H,5H,6H,7H,8H,9H-pyrazolo[3,4-b]quinolin-5-one Serine/threonine kinase glycogen synthase kinase-3 (GSK3) inhibitor.
D-924 [5-(3,4-Dimethoxyphenyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl][4-(2-methoxyphenyl)-1-piperazinyl]-methanone An agent that enhances the amplitude of circadian activity and induces intracellular cAMP levels.
B-918 1,3-Bis(8-acetyleno-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazepine-3-carboxy)propyl diester (XLi-093) Selective alpha5 GABA-A receptor antagonist.
N-907 (±)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1Hbenzo[d][1,2,3] triazole (Norvorozole) New! Aromatase PET imaging ligand [11C]vorozole labeling precursor.
B-919 (±)-trans-2-(4-Bromo-2,5-dimethoxybenzyl)-6-(2-methoxyphenyl)piperidine Hydrochloride New! Selective agonist for serotonin 5-HT2A receptor over the 5-HT2C receptor.
N-908 (R)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1H-benzo[d][1,2,3]triazole [(R)-(-)-Norvorozole] New! Aromatase PET imaging ligand [11C]vorozole labeling precursor.
N-909 (S)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1H-benzo[d][1,2,3]triazole [(S)-(+)-Norvorozole] Aromatase PET imaging ligand [11C]vorozole labeling precursor.
A-920 2-(5-{[3-(2-Aminoethyl)-1H-indol-5-yl]disulfanyl}-1H-indol-3-yl)ethan-1-amine Dipicrate (5-Mercaptotryptamine Picrate Dimer) New! A disulfide analog of serotonin.
V-905 [d(CH2)5(1), D-Tyr(2), Thr(4), Orn(8), des-Gly-NH2(9)]-Vasotocin TFA salt New! Selective oxytocin receptor antagonist.
L-907 N-(4-(4-(4-Methoxyphenyl)-1,4-diazepan-1-yl)butyl)-4-(thiophen-3-yl)benzamide (LAX-4-136) New! D3 dopamine receptor ligand
C-930 (2S)-2-Amino-4-(2-amino-4-chlorophenyl)-4-oxobutanoic acid trifluoroacetate New! Prodrug of the glycine binding site NMDA receptor antagonist 7-chlorokynurenine.
A-912 (Sp)-Adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt [(Sp)-cAMPS triethylammonium salt] Activator of cAMP-dependent protein kinases (cAMP agonist).
B-909 DL-threo-ß-Benzyloxyaspartic acid (DL-TBOA) Excitatory amino acid transporters inhibitor
A-913 (Rp)-Adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt [(Rp)-cAMPS triethylammonium salt] Competitive inhibitor of the activation of cAMP-dependent protein kinases by cAMP.
A-915 [5-Amino-1-(4-methoxyphenyl)sulfonylpyrazol-3-yl]benzoate NS3 West Nile virus protease inhibitor
A-904 (R)-(-)-2-Amino-5-phosphonopentanoic Acid anticonvulsant; potent & selective NMDA receptor antagonist
H-906 7alpha-(16-hydroxyhexadecyl)estra-1,3,5-trien-3,17beta-diol none
T-909 7alpha-[(3R/S,7R,11R)-3,7,11,15-tetramethylhexadecyl]estra-1,3,5-trien-3,17beta-diol none
H-905 7alpha-hexadecylestra-1,3,5-trien-3,17beta-diol none
C-711 Coenzyme A-S-acetyltryptamine Arylalkylamine N-acetyltransferase (AANAT) inhibitor.
C-504 7-Acetoxychlorpromazine Hydrogen Maleate
A-508 Acetoxyethyldimethylethylammonium Iodide
B-807 N-Acetyl-2-benzyltryptamine Melatonin receptor antagonist
D-523 N-Acetyl-3,4-dihydroxy-beta-phenethylamine
P-701 N-Acetyl-3-hydroxy-4-methoxy-beta-phenethylamine
P-703 N-Acetyl-4-methoxy-beta-phenethylamine
O-502 N-Acetyl-DL-octopamine
A-906 d7-N-Acetylserotonin weak melatonin receptor agonist
A-901 N-Acetyltyramine
A-903 ADAM Dihydrochloride
P-518 N-(2-Adamantyl)piperazine Dihydrochloride
A-502A Adapiperazine Dihydrochloride antiemetic; antipsychotic agent; dopamine antagonist
A-804 N-(beta-Alanyl)-L-DOPA Trifluoroacetate
A-805 N-(beta-Alanyl)tyrosine Trifluoroacetate
A-512 Alanylalanyl-6-hydroxydopamine Hydrochloride
A-902 N-beta-Alanyldopamine Hydrochloride Major precursor for sclerotin, an important constituent of insect cuticle
A-703 Allantoxanamide Uricase inhibitor
A-510 2-Amino-1-(3,4,5-trimethoxyphenyl)ethanol
A-511 2-Amino-1-(3,4-dimethoxyphenyl)ethanol Hydrochloride
A-514 6-Amino-2-chloro-9-(2'-O-methylsulfonyl-beta-D-xylofuranosyl)-9H-purine
M-801 (S)-2-Amino-2-methyl-4-phosphonobutanoic Acid potent group II/III metabotropic glutamate receptor agonist
C-535 3-Amino-3,4-dihydro-7-hydroxycarbostyril
H-525 2-Amino-4-hydroxy-beta-phenethylamine Dihydrobromide
I-707 2-(3-Amino-4-iodophenoxy)methylimidazoline Dihydrochloride Imidazoline-guaninidine binding site (IGRS) ligand
A-803 (RS)-1-Amino-5-phosphonoindan-1-carboxylic Acid Rigid MPPG analog; selective group II metabotropic glutamate receptor antagonist
T-510 2-Amino-DL-tyrosine
P-706 (±)-4'-Amino-PPHT
A-503 3-(2'-Aminobenzhydryloxy)tropane High affinity muscarinic ligand
A-701 cis-3-Aminocyclohexanecarboxylic Acid selective inhibitor of neuronal GABA uptake
A-504 3-(beta-Aminoethyl)-5-hydroxybenzo[b]thiophene 5-HT1E ligand
A-801 (RS)-1-Aminoindan-1,5-dicarboxylic Acid selective group I metabotropic glutamate receptor antagonist
N-701 p-Aminophenethylspiperone Dopamine D2 receptor antagonist; intermediate for photoaffinity agents
I-706 2-(3-Aminophenoxy)methylimidazoline Dihydrochloride Imidazoline-guaninidine binding site (IGRS) ligand
S-704 (±)-1-(4'-Aminophenyl)-7-bromo-8-methoxy-3-methyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine precursor to dopamine D1 receptor alkylating ligand (antagonist)
T-504 1-[2-(4-Aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine Dihydrochloride serotonin agonist
M-502 (±)-3-(2-Aminopropyl)-5-methoxyindole Hydrochloride
A-505 2-Aminotetralin Hydrochloride
A-507 5-Aminotryptamine Dipicrate serotonin agonist
A-905 Aniracetam antidepressive agent; nootropic Agent
A-704 APEC bis(Trifluoroacetate) Adenosine A2 receptor ligand
A-705 p-Aminophenylacetyl-APEC Functionalized A2 adenosine receptor ligand
A-914 Asenapine Maleate Antipsychotic agent; serotonin, dopamine and noradrenaline antagonist
A-806 Autonomium Iodide
Y-708 (±)-4-Azido-5-deschloro-YM-09151-02 Hydrochloride Reference standard for tritiated compound
Y-704 (±)-4-Azido-5-iodo-YM-09151-2 Dihydrochloride dopamine D2 receptor photoaffinity ligand
A-506 1-[2-(4-Azidophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine Hydrochloride selective photoaffinity labeling probe for the 5-HT1A receptor
B-701 N-[1-(2-Benzo[b]thiophenyl)cyclohexyl]piperidine Hydrochloride Potent & selective dopamine uptake inhibitor with little affinity for PCP sites
D-511 4'-Benzyloxy-2-dibenzylaminopropiophenone
P-517 4-Benzyloxy-3-methoxypyruvic Acid
C-505 8-Benzyloxy-7-methoxychlorpromazine
D-906 FITC-APEC A fluorescent ligand for A2a-Adenosine receptors.
B-139 (E)-7-Benzylidene-7-dehydronaltrexone Hydrochloride selective non-peptide delta1 opioid receptor antagonist
S-703 (±)-7-Bromo-1-[4'-(2-chloroethyl)aminophenyl]-8-hydroxy-3-methyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine Dihydrobromide dopamine D1 receptor alkylating ligand
C-705 (±)-7-Bromo-1-[4’-bis(2-chloroethyl)aminophenyl]-8-hydroxy-3-methyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine Hydrochloride dopamine D1 receptor alkylating ligand
B-806 1-Bromo-2,5-bis(4-hydroxystyryl)benzene
B-910 1-[4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone GPR30 (GPER1) agonist
B-911 4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline GPR30 (GPER1) antagonist
B-802 N-Bromoacetyl-beta-phenethylamine
B-801 N-Bromoacetylnaphthalene-2-ethylamine
B-803 N-Bromoacetyltryptamine potent & reversible inhibitor of melatonin secretion in the pineal gland
Q-707 N-(tert-Butyloxycarbonyl)-6-nitro-5-(trimethylstannyl)quipazine radioiodinated 5-HT uptake inhibitor precursor
A-513 N-(tert-Butyloxycarbonyl)alanylalanyl-6-hydroxydopamine
C-501 10-Carboethoxy-2-chlorophenothiazine
C-148 (-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane D-Tartrate Dopamine transporter radio-labeled ligand reference standard
C-801 (2S,1'S,2'S)-2-(Carboxycyclopropyl)glycine group II metabotropic glutamate receptor agonist
C-105 CGS 19755 competitive NMDA receptor antagonist; anticonvulsant and anti-ischemic
C-901 CGS 21680 Hydrochloride selective A2 adenosine receptor agonist
P-503 2-Chloro-10-(2-dimethylaminoethyl)phenothiazine Hydrochloride
P-504 2-Chloro-10-(3-dimethylamino-2-hydroxypropyl)phenothiazine Hydrogen Maleate
C-536 6-Chloro-2-methylmelatonin
D-524 DL-2-Chloro-3,4-dihydroxyphenylalanine Hydrobromide
D-525 DL-6-Chloro-3,4-dihydroxyphenylalanine Hydrobromide
D-518 DL-3-Chloro-4,5-dihydroxyphenylalanine Hydrobromide
C-802 (RS)-2-Chloro-5 hydroxyphenylglycine selective mGlu5 agonist
P-505 2-Chloro-6,9-dioxophenothiazine
P-506 (±)-2-Chloro-7,8-dioxo-10-(3-dimethylamino-2-hydroxypropyl)phenothiazine Hydrochloride
C-708 Chloro-IB-MECA Adenosine A3 receptor ligand
I-501 3-Chloro-N-desmethylimipramine Hydrochloride
A-509 N-(3-Chlorophenyl)-N-[gamma-N',N'-dimethylaminopropyl]aniline Hydrochloride
C-538 DL-p-Chlorophenylalanine serotonin antagonist
C-537 2-Chloropropadrine Hydrochloride
C-806 Chlorphentermine Hydrochloride sympathomimetic
C-503 Chlorpromazine Hydrochloride antipsychotic; antiemetic; slight antihisitamic & anti-adrenaline actions
C-529 nor1-Chlorpromazine Hydrochloride Chlorpromazine metabolite
C-530 nor2-Chlorpromazine Hydrochloride
C-526 Chlorpromazine Sulfone Hydrochloride
C-524 Chlorpromazine Sulfoxide Hydrochloride antiemetic; antipsychotic agent; dopamine antagonist
C-532 nor1-Chlorpromazine Sulfoxide Hydrochloride
C-531 nor2-Chlorpromazine Sulfoxide Hydrochloride
C-701 Chlorpromazine-10-spermidine Dihydrochloride Potential prodrug for polyamines
C-525 Chlorpromazine-N-oxide antiemetic; antipsychotic agent; dopamine antagonist
C-707 Chrysamine G
C-908 Ciproxifan potent, selective H3 histamine receptor antagonist
C-904 Clopidogrel Hydrogen Sulfate platelet aggregation inhibitor
C-905 Clorgyline Hydrochloride antidepressive agent; monoamine oxidase inhibitor
C-807 Clozapine selective D4-dopamine receptor antagonist
C-910 Coenzyme A-S-acetyl-2-naphthylen-1-ylethylamine Ligand for melatonin rhythm enzyme arylalkylamine-N-acetyltransferase (AANAT)
C-902 Coenzyme A-S-acetyl-L-DOPA
C-920 6-Cyano-7-nitroquinoxaline-2,3-dione Disodium Salt (CNQX Disodium Salt) AMPA/kainate receptor antagonist
C-706 Cyanopindolol Fumarate adrenergic -antagonist; serotonin antagonist
C-919 Cyclohexylcarbamic Acid 3’-Carbamoylphenyl-3-yl Ester (URB597) Fatty acid amide hydrolase (FAAH) inhibitor.
C-804 (RS)-alpha-Cyclopropyl-4-phosphonophenylglycine potent group III mGlu antagonist
C-702 5-(S)-Cysteinyl-L-DOPA melanoma biomarker
C-903 5-(S)-Cysteinyl-DOPAC Hydrochloride
C-805 5-(S)-Cysteinyldopamine May be involved in neural degeneration characteristic of Parkinson's disease; dopamine metabolite
D-803 DASB Hydrochloride high-affinity serotonin transporter ligand
Y-705 (±)-5-Deschloro-4-desmethyl-YM-09151-2 precursor to radiolabeled 4-azido-5-iodo-YM-09151-2
T-902 (+)-(2R,3R,11bR)-9-O-Desmethyl-alpha-dihydrotetrabenazine Starting material for synthesis of carbon-11 labeled (+)-alpha-dihydrotetrabenazine ([11C]DTBZ)
D-804 Desmethyl-DASB 11C-labeled DASB precursor (cf. D-803)
N-704 (+)-N-Desmethyl-NNC 01-0112 Hydrochloride Precursor to [11C]-NNC-01-01
T-511 N-Desmethyltriflupromazine Hydrochloride
P-520 3,4-Di(beta-dimethylaminoethoxy)-beta-phenethylamine Trihydrochloride
D-521 3,4-Di(beta-trimethylammoniumethoxy)-beta-phenethylamine Dichloride Hydrochloride
C-506 7,8-Diacetoxychlorpromazine Hydrogen Maleate
P-519 1,4-Diacryloylpiperazine cross-linking monomer for development of polyacrylamide gels
Q-901 2-[2-(4-Dibenzo[b,f][1,4]thiazepine-11-yl-1-piperazinyl)ethoxy]ethanol Fumarate (Quetiapine Fumarate) antipsychotic agent
D-514 L-3,4-Dibenzoyloxyphenylalanine Na-K-ATPase inhibitor
P-514 2,4-Dibenzyloxy-5-methoxyphenylacetic Acid
P-521 3,4-Dibenzyloxy-beta-phenethylamine Hydrochloride
C-508 7,8-Dibenzyloxychlorpromazine
D-702 3-(4',4''-Dibromobenzhydryloxy)tropane Hydrochloride Dopamine uptake inhibitor
D-802 (2S,1'R,2'R,3'R)-2-(2',3'-Dicarboxylcyclopropyl)glycine anticonvulsant; selective group II mGluR agonist
B-711 2',4'-Dichlorobenzamil Hydrochloride inhibitor of the sodium/calcium exchanger
B-710 3',4'-Dichlorobenzamil Hydrochloride inhibitor of the sodium/calcium exchanger
D-529 2,4-Dichloropromazine Hydrochloride
I-502 N,N-Didesmethylimipramine Hydrochloride
R-501 1-(beta-Diethylamino)ethylreserpine Dipicrate hypotensive agent
D-522 3,4-Diethylcarbonato-beta-phenethylamine Carbamate
D-904 d2-Dihydroouabain antagonist of ouabain inotropic action
D-905 (-)-alpha-Dihydrotetrabenazine Optical isomer of putative tetrabenazine metabolite alpha-dihydrotetrabenazine
T-802 (+)-alpha-Dihydrotetrabenazine Active metabolite of tetrabenazine with high affinity for the vesicular monamine transporter (VMAT2)
D-701 (±)-5,6-Dihydroxy-2-(N,N-dimethyl)aminotetralin Hydrobromide
D-519 2,3-Dihydroxy-beta-phenethylamine Hydrobromide
D-520 2,4-Dihydroxy-beta-phenethylamine Hydrochloride
C-512 7,8-Dihydroxy-N,N-didesmethylchlorpromazine Hydrochloride
H-512 DL-2-(3,4-Dihydroxybenzyl)-2-hydrazinopropionic Acid antiparkinson agent; dopaminergic agent
C-511 7,8-Dihydroxychlorpromazine Hydrochloride
D-509 5,6-Dihydroxyindole catechol O-methyltransferase (COMT) inhibitor
P-501 7,8-Dihydroxyperphenazine Dihydrochloride
S-501 D-(+)-threo-3-(3,4-Dihydroxyphenyl)serine
S-502 L-(-)-threo-3-(3,4-Dihydroxyphenyl)serine
D-515 (+)-2,4-Dihydroxyphenylalanine
D-517 (-)-2,4-Dihydroxyphenylalanine
D-512 (±)-2,4-Dihydroxyphenylalanine
D-516 DL-3,4-Dihydroxyphenylalanyl-GABA
D-505 3,4-Dihydroxyphenylethanol 1,4-Diazabicyclo[2.2.2]octane anti-infective agent; antioxidant; platelet aggregation inhibitor
D-506 3,4-Dimethoxy-5-hydroxybenzoic Acid thiopurine methyltransferase inhibitor
P-522 2,5-Dimethoxy-beta-phenethylamine Hydrochloride
C-513 7,8-Dimethoxychlorpromazine Hydrochloride
D-916 3-(2,5-Dimethoxyphenyl)-6-(3,4-dimethoxy¬phenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine Phosphodiesterase type 4 (PDE4) inhibitor
P-515 2,4-Dimethoxyphenylacetic Acid
D-528 DL-(N,N-Dimethyl)ephedrine Iodide
F-902 N,N-Dimethyl-2-(2-amino-4-fluorophenylthio)benzylamine PET imagining agent for serotonin transporters (when labeled with fluorine-18)
D-507 alpha-Dimethylamino-3,4-dihydroxyacetophenone Methachloride
I-902 2-(4’-N,N-Dimethylaminophenyl)-6-(tributylstannyl)imidazo[1,2-a]pyridine Precursor for radio-iodinated IMPY
I-901 2-(4’-N,N-Dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine Beta-amyloid aggregate-specific ligand
D-915 2-(3-Dimethylaminophenyl)-7,8-dihydroxy-4H-chromen-4-one 7,8-Dihydroxyflavone analog.
D-513 4-(gamma-N,N-Dimethylaminopropylamino)phenol Dimaleate
H-518 N,N-Dimethylhistamine Methiodide
I-705 1,2-Dimethylisoquinolinium Iodide
C-514 7,8-(Dimethylmethylenedioxy)chlorpromazine
C-907 N,N-Dinorcitalopram Oxalate citalopram metabolite
C-516 7,8-Dioxo(N,N-didesmethyl)chlorpromazine Hydrochloride
C-515 7,8-Dioxochlorpromazine Hydrochloride
D-805 1,2-Dithiole-3-thione antineoplastic agent
B-705 (R)-(+)-5-(1,3-Dimethylbutyl)-5-ethylbarbituric Acid Convulsant
B-704 (S)-(-)-5-(1,3-Dimethylbutyl)-5-ethylbarbituric Acid Sedative, hypnotic
D-901 L-DOPA-ring-d3 antiparkinson agent
G-502 Dopamine-4-O-beta-D-glucuronide
D-504 Dopamine-4-O-sulfate possible norepinephrin precursor
E-704 EHPG Piperazine Salt catecholamine turnover biomarker
E-709 (E)-2-Enevalproate, Sodium Salt Valproic acid metabolite
E-708 (E)-2-Enevalproic Acid anticonvulsant; valproic acid metabolite
E-703 Epidepride Highly lipophilic dopamine D2 receptor antagonist
E-901 Iodine-125 Labeled Epidepride picomolar dopamine D2 receptor ligand
C-502 N-Ethyl-2-chlorophenothiazine
T-506 5-Ethyl-5-(1'-methyl-3'-hydroxybutyl)-2-thiobarbituric Acid Thiopental metabolite
B-501 5-Ethyl-5-(3’-hydroxy-1’-methylbutyl)barbituric Acid pentobarbitol metabolite
E-706 DL-alpha-Ethylmethionine-(S,R)-sulfoximine Glutamate synthetase inhibitor
E-701 N-Ethylnornicotine Internal standard for mass spectrometry
F-901 FK866 nicotinamide phosphoribosyltransferase inhibitor
N-502 6-Fluoronorepinephrine Oxalate - & -adrenergic-sensitive cyclic AMP-generating systems activator
F-908 1-(2-(4-(1-(4-Fluorophenyl)-5-(1-methyl-1H-1,2,4-triazol-5-yl)-1H-indol-3-yl)-1-piperidinyl)ethyl)imidazolidin-2-one alpha1-Adrenoceptor antagonist; a1-adrenoceptor PET ligand reference standard.
F-909 1-(2-(4-(1-(4-Fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indol-5-yl)-1-piperidinyl)ethyl)imidazolidin-2-one alpha1-Adrenoceptor PET ligand labeling precursor.
F-132 (±)-Fluoxetine Hydrochloride serotonin uptake inhibitor; second-generation antidepressive agent
G-801 GBR 12909 Dihydrochloride dopamine reuptake inhibitor with behavioral effects similar to cocaine
G-501 gamma-Glutamyldopamine
G-802 gamma-L-Glutamylserotonin
M-903 [(-)-(R)-Methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)methyl]-1-piperazinecarboxylate fumarate selective opioid receptor agonist
H-520 2-Hydrazino-3-(4-hydroxyphenyl)propionic Acid inhibitor of fungal tyrosinase
B-804 N-[2-(7-Hydroxy-1-naphthyl)ethyl]-2-bromoacetamide
H-903 N-[2-(7-hydroxy-1-naphthyl)ethyl]amine Hydrochloride Serotonin N-acetyltransferase inhibitor
H-902 2-(5-Hydroxy-1H-indol-3-ylmethyl)thiazolidine-4-carboxylic Acid Potassium Salt
H-904 6-Hydroxy-2-(4-hydroxyphenyl)-3-[(2E, 6E)-3,7,11-trimethyl-dodeca-2,6,10-trienyl]-[1,4]-naphthoquinone leave blank
R-701 17alpha-Hydroxy-20alpha-yohimban-16beta-(N-4-aminophenethyl)carboxamide radioiodinated 2 adrenergic ligand precursor
H-523 4(3)-Hydroxy-3(4)-(beta-dimethylaminoethoxy)-beta-phenethylamine Dihydrochloride
H-527 4(3)-Hydroxy-3(4)-(beta-trimethylammoniumethoxy)-beta-phenethylamine Chloride Hydrochloride
H-515 beta-(5-Hydroxy-3-benzo[b]thienyl)-alpha-aminopropionic Acid
H-908 {4-[4-hydroxy-3-isopropyl-5-(4-nitrophenylethynyl)benzyl]-3,5-dimethylphenoxy}acetic acid (NH-3) ß-subtype selective thyroid hormone receptor antagonist
H-513 3-(4-Hydroxy-3-methoxyphenyl)-1-propanol
P-528 (±)-4-Hydroxy-3-methoxyphenylpropyleneglycol 1,4-Diazabicyclo[2.2.2]octane lignin model compound
P-526 3-Hydroxy-4-methoxy-DL-phenylalanine
H-502 5-Hydroxy-6-methoxytryptamine Creatinine Sulfate
H-503 5-Hydroxy-7-methoxytryptamine Creatinine Sulfate
H-522 2-Hydroxy-beta-phenethylamine Hydrochloride
H-701 (±)-7-Hydroxy-DPAT Hydrobromide selective D3 dopamine agonist
H-704 (R)-(+)-7-Hydroxy-2-(N,N-dipropylamino)tetralin Hydrobromide
C-520 7-Hydroxy-N-desmethylchlorpromazine Hydrochloride Chlorpromazine metabolite
I-504 2-Hydroxy-N-desmethylimipramine tricyclic antidepressive agent
H-705 (±)-trans-7-Hydroxy-PIPAT Hydrochloride selective D3 dopamine receptor agonist
H-521 3-Hydroxybenzylamine
C-518 7-Hydroxychlorpromazine Hydrochloride antiemetic; antipsychotic agent; dopamine antagonist
C-521 7-Hydroxychlorpromazine Methiodide antiemetic; antipsychotic agent; dopamine antagonist
C-528 7-Hydroxychlorpromazine Sulfoxide
C-519 7-Hydroxychlorpromazine-O-beta-D-glucuronide 7-hydroxychlorpromazine metabolite
D-501 6-Hydroxydopamine Hydrobromide Neurotoxin at catecholaminergic terminals
D-502 6-Hydroxydopamine Hydrochloride Neurotoxin at catecholaminergic terminals
C-803 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate Ethyl Ester potent, selective, non-competitive mGluR1 antagonist
I-503 2-Hydroxyimipramine
H-501 5-Hydroxyindole-3-beta-propionic Acid GC/MS internal standard for catecholamine assay
H-516 3-(3-Hydroxyphenyl)-N-(n-propyl)piperidine Hydrobromide antiparkinson agent; dopaminergic agent
H-526 threo-beta-(4-Hydroxyphenyl)serine
H-901 4-Hydroxyphenylacetaldehyde
H-528 4-Hydroxyphenylglycol Octopamine metabolite
H-113 2-Hydroxysaclofen potent & selective GABAB receptor antagonist
H-907 (Z)-4-Hydroxytamoxifen estrogen receptor agonist
H-504 4-Hydroxytryptamine Creatinine Sulfate
H-505 6-Hydroxytryptamine Creatinine Sulfate
H-510 4-Hydroxytryptophan Hemiacetate
I-903 [3H]I-NBMeO (N-[2-methoxy-3H]-(2-methoxybenzyl)-[2-methoxy-3H]-(2,5-dimethoxy-4-iodophenethylamine) 5-HT2A agonist
I-801 IDAM Hydrochloride unlabeled analog of a SPECT serotonin transporter imaging agent
I-709 Inositol Phosphate, Arylbis(phosphonate) Analog, Dipotassium Salt
Q-708 5-Iodo-6-nitroquipazine Selective inhibitor of 5-HT uptake sites
M-144 (+)-3-Iodo-MK-801 Hydrochloride Analog of the NMDA antagonist MK-801
M-141 (-)-3-Iodo-MK-801 Hydrochloride Analog of the NMDA antagonist MK-801
Y-706 (±)-4'-Iodo-YM-09151-02 Potential high affinity probe for dopamine D2 receptors
I-701 IsoMHPG
I-906 (R)-2-Isopropylpentanoic Acid (R)-Enantiomer of PIA, a non-teratogenic constitutional isomer of the anticonvulsant drug valproic acid.
I-907 (S)-2-Isopropylpentanoic Acid (S)-Enantiomer of PIA, a non-teratogenic constitutional isomer of the anticonvulsant drug valproic acid.
I-505 (±)-Isosalsoline Hydrochloride
I-124 Isradipine antihypertensive Agent; calcium channel blocker; vasodilator
J-901 JMV-431 Neurotensin receptor-2 agonist
K-501 Kawain anticonvulsant; anti-anxiety agent
K-701 Kemptide Fluorescein Fluorescently-labeled marker for protein kinase A (PKA)
L-901 beta-Lactotensin neurotensin agonist active at the NT2 receptor
M-901 (+)-McN-5652 S-Desmethyl-S-butyryl Ester D-Tartrate Precursor to [11C]-(+)-McN-5652
M-706 (+)-McN-5652 S-Desmethyl-S-butyryl Ester Precursor to [11C]-(+)-McN-5652
M-707 (+)-McN-5652 serotonin transporter inhibitor (active enantiomer)
M-708 (-)-McN-5652 serotonin transporter inhibitor (inactive enantiomer)
M-704 (±)-McN-5652 Serotonin transporter inhibitor
M-802 L-anti-endo-3,4-Methaneopyrrolidinedicarboxylic Acid inhibitor of the Na-dependen, high-affinity synaptosomal Glu transporter
M-902 5-Methoxy-1-isopropyltryptamine Oxalate
M-501 1-(3-Methoxy-4-hydroxyphenyl)-1-hydroxy-2-aminopropane Hydrogen Oxalate
M-508 DL-3-Methoxy-alpha-methyl-DOPA-4-O-sulfate, Potassium Salt
C-523 7-Methoxychlorpromazine Hydrochloride
M-506 6-Methoxymelatonin 6-hydroxymelatonin metabolite
P-509 2-Methoxyphenothiazine
M-503 6-Methoxytryptamine Creatinine Sulfate
I-703 (±)-1-Methyl-1,2,3,4-tetrahydroisoquinoline Hydrochloride Potential dopaminergic neurotoxin
M-804 (2S,3S,4S)-2-Methyl-2-(carboxycyclopropyl)glycine Group II metabotropic glutamate receptor antagonist
P-511 N-Methyl-2-(trifluoromethyl)phenothiazine
M-701 1-Methyl-4-(2’-methylphenyl)pyridinium Iodide
D-503 2-Methyl-6-hydroxydopamine Hydrobromide
B-504 N-Methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide Oxalate muscarinic partial agonist (oxotremorine analog)
M-509 (±)-2-Methylamino-1-phenylethanol type A & B monoamine oxidase substrate
E-707 L-N-Methylepinephrine L-Tartrate
M-507 (R)-(-)-alpha-Methylhistamine 1.5 Oxalate
H-517 2-Methylhistamine Dipicrate
H-509 4-Methylhistidine Hydrochloride
H-507 alpha-Methylhistidine Hydrochloride
I-704 1-Methylisoquinoline Hydrochloride Potential dopaminergic neurotoxin
P-510 N-Methylphenothiazine
M-803 (RS)-alpha-Methylserine-O-phosphate mGLuR antagonist
M-710 1-Methylserotonin Hydrogen Maleate
M-504 alpha-Methylserotonin Hydrogen Oxalate
M-709 1-Methyltryptamine Hydrochloride Methylated tryptamine
M-711 5-Methyltryptamine Hydrogen Maleate Serotonin analog
M-712 6-Methyltryptamine Hydrogen Maleate Serotonin analog
M-510 N-Methyltyramine Hydrobromide
M-703 Mifepristone Progesterone receptor antagonist; stimulates prolactin secretion
M-107 (+)-MK-801 Hydrogen Maleate selective, non-competitive NMDA glutamate receptor antagonist
M-916 2-(4-Morphin-4-ylphenyl)-7,8-dihydroxy-4H-chromen-4-one 7,8-Dihydroxyflavone analog.
N-804 [3H]-(S)-(-)-N-0437 dopamine receptor agonist
C-912 N-Caffeoylnorepinephrine
C-911 N-Cinnamoylnorepinephrine
C-913 N-Coumaroyldopamine
C-914 N-Coumaroyloctopamine
F-903 N-feruloylnorepinephrine
F-904 N-Feruloyltramine
T-702 (R)-(-)-N-Methyl-3-(2-iodophenoxy)-3-phenylpropanamine Hydrochloride Norepinephrine transport inhibitor
N-801 (±)-N-Norfenfluramine Hydrochloride serotonin uptake inhibitor
N-802 (R)-(-)-N-Norfenfluramine Hydrochloride
N-803 (S)-(+)-N-Norfenfluramine Hydrochloride
C-909 (R)-(+)-N-trans-p-Coumaroylnoradrenaline Plant metabolite implicated in tomato defense against pathogens
X-901 NIMH Inventory Screening Plates
N-901 (±)-Nisoxetine Hydrochloride norepinephrine uptake inhibitor
N-705 6-Nitrodopamine Nitrated catecholamine
N-706 6-Nitronorepinephrine Nitrated catecholamine
N-703 (+)-NNC 01-0112 dopamine D1 receptor ligand
N-904 R-(-)-Norapomorphine Hydrobromide Dopamine receptor agonist. Dopamine receptor PET ligand [11C](-)-N-propylnorapomorphine labeling precursor.
C-906 N-Norcitalopram Oxalate citalopram metabolite
N-702 (+)-Norepinephrine (+)-Tartrate Unnatural enantiomer of norepinephrine
N-707 Norepinephrine-3-O-sulfate catechol O-methyltransferase inhibitor
D-902 (±)-O-Desethylreboxetine
O-501 D-(-)-Octopamine biogenic amine formed by -hydroxylation of tyramine; adrenergic
O-901 Olanzapine serotonin uptake inhibitor
O-801 [3H][Thr4,Gly7]Oxytoxin
P-710 PD149163 Neurotensin agonist; some CNS activity similar to atypical antipsychotics
P-512 Phenothiazine-5-oxide
P-801 (±)-4-Phenyl-2-(propioamido)tetralin melatonin receptor antagonist
P-802 [3H]4-Phenyl-2-(propioamido)tetralin melatonin receptor antagonist
P-804 (±)-4-Phenyl-2-[2',2',3'-2H]-(propioamido)tetralin
P-805 PNU-101,958
P-901 [3H]PNU-101,958
P-513 nor1-Promazine Sulfoxide Hydrochloride
P-707 (R)-(+)-2-(N-Propargyl-N-propyl)amino-7-hydroxytetralin Hydrochloride Precursor to radiolabeled (R)-(+)-7-hydroxy-DPAT
P-708 (R)-(-)-2-(N-Propargyl-N-propyl)amino-8-hydroxytetralin Hydrochloride precursor to radiolabeled (R)-(Ð)-8-hydroxy-DPAT
D-041 (S)-(+)-N-Propylnorapomorphine Hydrochloride limbic-selective dopamine antagonist
P-803 3-(R)-[2-(S)-(Pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) MSH release-inhibiting hormone antagonist
R-902 (±)-Reboxetine Mesylate antidepressive agent; adrenergic uptake inhibitor
R-901 Risperidone serotonin antagonist; antipsychotic agent; dopamine antagonist
R-702 RU-24969 Hemisuccinate 5-HT1A/1B agonist
S-504 (±)-Salsoline Hydrochloride salsolinol metabolite; endogenous neurotoxin
S-505 (±)-Salsolinol Hydrochloride Neurotoxic derivative of dopamine
S-803 Serotonin-O-beta-D-glucuronide
S-503 Serotonin-O-sulfate
S-905 SIB-1508Y Agonist for neuronal nicotinic acetylcholine-gated ion channels
S-903 SIB-1553A nicotinic acetylcholine receptor agonist; possible cognitive enhancer
S-701 SKF-104078 2-adrenergic antagonist
S-101 (R)-(+)-SKF-38393 Hydrochloride D1 dopamine receptor agonist; active enantiomer of (±)-SKF-38393
S-906 SKF-81297 Hydrobromide dopamine agonist
S-907 SKF-82958 Hydrobromide dopamine agonist
S-904 SKF-83822 Hydrobromide Agonist at dopamine D1-like receptors that stimulate adenylyl cyclase
S-706 SKF-83959 Hydrobromide dopamine D1 receptor agonist
S-901 Spiperone dopamine D2 receptor antagonist; antipsychotic
S-705 SR 141716 CB1 cannabinoid receptor antagonist
S-902 SR 142948 Potent neurotensin receptor antagonist
S-801 SR 144528 CB2 cannabinoid receptor antagonist
S-802 SR 48692 non-peptide neurotensin receptor antagonist
S-908 SR147778 CB1 antagonist
A-702 N6-p-Sulfophenyladenosine Triethylamine Salt Water-soluble, selective adenosine A1 receptor agonist
T-905 (+)-Tetrabenazine
T-904 (-)-Tetrabenazine
T-901 (±)-Tetrabenazine Dopamine depleting agent; antipsychotic; antidyskinetic
I-702 1,2,3,4-Tetrahydroisoquinoline Hydrochloride Potential dopaminergic neurotoxin
T-703 1-[1-(2-Thienyl)cyclohexyl]morpholine
T-906 Thioperamide Maleate anticonvulsant; histamine antagonist
T-907 Tolcapone antiparkinson agent
B-901 trans-Bis-Q [trans-3,3'-bis[alpha-trimethylammonum)methyl]azobenzene dibromide] photochromic acetylcholine receptor activator
A-808 Tributylstannyl-ADAM Precursor for radioiodinated ADAM
T-501 Trifluoperazine-5-oxide
T-507 2,3,4-Trihydroxy-beta-phenylethylamine Hydrochloride potential neurotoxin; arylsulfatase inhibitor
T-508 2,3,4-Trihydroxy-DL-phenylalanine Neurotoxic DOPA metabolite
H-511 5-(2,4,5-Trihydroxybenzyl)hydantoin
T-503 5,6,7-Trihydroxytryptamine Creatinine Sulfate
D-510 5,6,7-Trimethoxy-N,N-dimethyltryptamine
P-516 3,4,5-Trimethoxyphenylacetic Acid Mescaline metabolite
M-145 (+)-3-Trimethylsilyl-MK-801 Hydrochloride Precursor to radioiodinated (+)-3-iodo-MK-801
M-143 (-)-3-Trimethylsilyl-MK-801 Hydrochloride precursor to radioiodinated (Ð)-3-iodo-MK-801
Y-707 (±)-4'-Trimethylstannyl-YM-09151-02 radioiodinated 4'-iodo-YM-09151-02 precursor
E-705 5-Trimethylstannylepidepride Precursor for radioiodinated epidepride (D2 antagonist)
T-908 7alpha-[(4R,8R)-4,8,12-Trimethyltridecyl]estra-1,3,5(10)-trien-3,17beta-diol
U-802 Tritiated U-101,958 (N-methyl-3H)
U-801 Tritiated UH-301 serotonin antagonist
T-704 Tropapride Hydrochloride dopamine D2 receptor antagonist
T-502 L-(-)-Tyrosine-O-sulfate Potassium Salt
U-703 (S)-(-)-N-Propargyl-UH-301 Hydrochloride
H-703 Velnacrine Maleate Cholinesterase inhibitor
V-902 Ethyl 4-{2-[(2-methylbenzoyl)amino]ethylamino}piperidine-1-carboxylate Hydrochloride (VU0357017 Hydrochoride) Muscarinic acetylcholine receptor subtype 1 (M1) allosteric agonist.
W-501 W-5 [N-(6-Aminocyclohexyl)-1-naphthalenesulfonamide Hydrochloride] calmodulin antagonist
W-502 W-7 [N-(6-Aminocyclohexyl)-5-chloro-1-naphthalenesulfonamide Hydrochloride] calmodulin antagonist
W-901 WAY 405 Selective 5-HT1A receptor antagonist
W-108 WAY-100635 Maleate serotonin receptor antagonist
W-801 WRC-0571 serotonin receptor antagonist
Y-701 (±)-YM-09151-2 (Nemonapride) Selective dopamine D2 receptor antagonist; antipsychotic
Y-703 (+)-YM-09151-2 Enantiomer of (±)-YM-09151-2
Y-702 (-)-YM-09151-2 antipsychotic agent; dopamine antagonist
Z-901 (±)-Zacopride Hydrochloride Highly potent 5-HT3 receptor antagonist & 5-HT4 receptor agonist
Z-902 Zonisamide anticonvulsant; antioxidant

About The Program

Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.

Content © 2014. «RTI International».